Performance of and Factors Associated With Tuberculosis Screening and Diagnosis Among People Living With HIV: Analysis of 2012-2016 Routine HIV Data in Tanzania.

HIV Tanzania diagnosis screening tuberculosis

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2019
Historique:
received: 17 06 2019
accepted: 18 12 2019
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 3 3 2020
Statut: epublish

Résumé

People Living with HIV (PLHIV) should be screened for tuberculosis (TB) at every visit to the HIV care and treatment clinic (CTC), and those with positive results on screening should undergo further diagnostic investigations. We evaluated the performance of the TB diagnosis cascade among PLHIV attending CTC between January 2012 and December 2016 in three regions of Tanzania: Dar es Salaam, Iringa, and Njombe. We used descriptive epidemiology to evaluate performance and logistic regression to determine odds ratios (OR) for factors associated with TB screening and further TB diagnosis after positive TB screening. We analyzed 169,741 PLHIV who made 2,638,876 visits to CTC between January 2012 and December 2016. We excluded 2,074 (0.80%) visits as these involved PLHIV enrolled in CTC with a prior TB disease diagnosis. Of the 2,636,802 visits, 2,524,494 (95.67%) had TB screening according to national guidelines, of which 88,028 (3.49%) had TB screening positive results. Of the 88,028 visits with a positive TB screening, 27,810 (31.59%) had no records for further TB diagnosis following positive TB screening. Of all visits with positive TB screening, 32,986 (37.50%) had a TB disease diagnosis. On multivariate logistic regression, those who visited with World Health Organization (WHO) clinical stage four (aOR = 3.61, 95% CI 3.48-3.75,

Identifiants

pubmed: 32117844
doi: 10.3389/fpubh.2019.00404
pmc: PMC7015871
doi:

Types de publication

Journal Article

Langues

eng

Pagination

404

Informations de copyright

Copyright © 2020 Maokola, Ngowi, Lawson, Mahande, Todd and Msuya.

Références

Int J Tuberc Lung Dis. 2016 Jan;20(1):79-84
pubmed: 26688532
Glob Health Action. 2016 Aug 26;9:32390
pubmed: 27569593
J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S270-3
pubmed: 25768866
BMC Public Health. 2016 Jul 13;16:563
pubmed: 27412114
PLoS One. 2015 Feb 06;10(2):e0116721
pubmed: 25658091
Int J Mycobacteriol. 2015 Mar;4(1):1-6
pubmed: 26655191
AIDS Rev. 2010 Oct-Dec;12(4):183-94
pubmed: 21179183
Front Public Health. 2019 Oct 24;7:306
pubmed: 31709218
BMC Public Health. 2019 Jan 8;19(1):29
pubmed: 30621655
Natl Med J India. 2016 Nov-Dec;29(6):321-325
pubmed: 28327478
Open Forum Infect Dis. 2014 Oct 10;1(3):ofu095
pubmed: 25734163
BMC Res Notes. 2012 Jan 26;5:67
pubmed: 22277087
PLoS One. 2017 Mar 10;12(3):e0173309
pubmed: 28282390
N Engl J Med. 2010 Feb 25;362(8):707-16
pubmed: 20181972
Curr Opin HIV AIDS. 2017 Mar;12(2):129-138
pubmed: 28059955
PLoS Med. 2011 Jan 18;8(1):e1000391
pubmed: 21267059
BMC Infect Dis. 2017 Aug 4;17(1):543
pubmed: 28778187
BMC Health Serv Res. 2019 Sep 4;19(1):628
pubmed: 31484571

Auteurs

Werner Maokola (W)

National AIDS Control Program/Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi Urban, Tanzania.

Bernard Ngowi (B)

National Institute of Medical Research, Dar es Salaam, Tanzania.

Lovetti Lawson (L)

Zanklin Medical Center, Abuja, Nigeria.

Michael Mahande (M)

Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi Urban, Tanzania.

Jim Todd (J)

Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi Urban, Tanzania.
London School of Hygiene and Tropical Medicine, London, United Kingdom.

Sia E Msuya (SE)

Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi Urban, Tanzania.

Classifications MeSH